The US Food and Drug Administration has okayed removal of the contraindication for use during CT and MRI under certain ...

Users of the FreeStyle Libre 2 and 3 continuous glucose monitoring systems from Abbott no longer need to remove and discard the devices for imaging procedures, such as X-rays, CT ...

Combine continuous glucose monitoring data from the FreeStyle Libre 2 system, from wherever you are*, along with expert advice from your health coach help you make informed decisions to keep enjoying ...

Beta Bionics announced today that it launched the integration of the iLet bionic pancreas with the Abbott (NYSE:ABT) ...

Abbott today announced that its FreeStyle Libre 2 and 3 systems can now be worn during common imaging procedures, such as X-rays, CT scans and MRIs*. The U.S. Food and Drug Administration (FDA) ...

Tidepool today announced a new data integration with Abbott for the company's FreeStyle Libre continuous glucose monitors ...

A major development towards the goal of patient and provider choice, the cloud-to-cloud integration will provide an automatic ...

Beta Bionics has launched the integration of its flagship iLet Bionic Pancreas with Abbott’s FreeStyle Libre 3 Plus sensor.

We expect the company to post a mid-single-digit uptick in revenue, driven by higher FreeStyle Libre sales. Our interactive dashboard analysis of Abbott’s FY 2024Q3 Earnings Preview has more ...

For individuals living with Type 2 diabetes, managing blood sugar levels can feel like walking a tightrope. The delicate balance between medication, diet and lifestyle often leaves many feeling ...

IRVINE, CA / ACCESSWIRE / October 30, 2024 / Beta Bionics, Inc., a pioneering leader in the development of advanced diabetes ...

Tidepool collaborates with Abbott for seamless data integration with its FreeStyle Libre portfolio in the U.S., expanding patient choice and streamlining diabetes care workflows. Tidepool ...